These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 22605623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Maintenance infliximab therapy in patients with Crohn's disease: how long, how much, how frequent?
    Cuffari C, Lichtenstein GR.
    Gastroenterology; 2003 Jun; 124(7):1988-90. PubMed ID: 12806638
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inflammatory polypoid mass treated with Infliximab in a Crohn's disease patient.
    Liatsos C, Kyriakos N, Panagou E, Karagiannis S, Salemis N, Mavrogiannis C.
    J Crohns Colitis; 2010 Dec; 4(6):707-8. PubMed ID: 21122587
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity of infliximab in Crohn's disease.
    Hanauer SB.
    N Engl J Med; 2003 May 22; 348(21):2155-6; author reply 2155-6. PubMed ID: 12761378
    [No Abstract] [Full Text] [Related]

  • 13. Severe agranulocytosis following first infliximab infusion in Crohn's disease.
    Rosales-Zábal JM, Fernández-Pérez F, Albandea-Moreno C, Vera-Rivero FM, Navarro-Jarabo JM.
    Inflamm Bowel Dis; 2011 Nov 22; 17(11):E147-8. PubMed ID: 21830280
    [No Abstract] [Full Text] [Related]

  • 14. Histological inflammation in Crohn's disease in deep remission during treatment with anti-TNFα.
    Tursi A, Elisei W, Picchio M, Brandimarte G.
    Dig Liver Dis; 2014 Jun 22; 46(6):575-6. PubMed ID: 24602485
    [No Abstract] [Full Text] [Related]

  • 15. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception.
    Angelucci E, Cocco A, Viscido A, Caprilli R.
    Inflamm Bowel Dis; 2008 Mar 22; 14(3):435-6. PubMed ID: 18050300
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outcome after discontinuation of TNFα-blocking therapy in patients with inflammatory bowel disease in deep remission.
    Molander P, Färkkilä M, Salminen K, Kemppainen H, Blomster T, Koskela R, Jussila A, Rautiainen H, Nissinen M, Haapamäki J, Arkkila P, Nieminen U, Kuisma J, Punkkinen J, Kolho KL, Mustonen H, Sipponen T.
    Inflamm Bowel Dis; 2014 Jun 22; 20(6):1021-8. PubMed ID: 24798636
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.
    Jahnsen J, Detlie TE, Vatn S, Ricanek P.
    Expert Rev Gastroenterol Hepatol; 2015 Jun 22; 9 Suppl 1():45-52. PubMed ID: 26395534
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.